Johnson & Johnson will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the US claiming its talc products caused ovarian cancer. The deal involves a third bankruptcy filing of J&J subsidiary LTL Management to resolve the lawsuits. A three-month voting period will start for claimants to agree on a settlement for nearly all current and future ovarian cancer claims related to talc. At the same time, separate arrangements will handle the remaining mesothelioma lawsuits. J&J has already resolved 95% of mesothelioma lawsuits filed to date.
